ApprovalTrail

Drug · DIN 02386313

SIMVASTATIN

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since May 31, 2022; first marketed June 12, 2012.
Drug Identification Number (DIN)
02386313
Company (DIN owner)
Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Simvastatin C10AA01
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
SIMVASTATIN20 MG

Notices of Compliance

Health Canada approvals that name this DIN.

  • October 1, 2021: NOC 26752Abbreviated New Drug Submission (ANDS)
  • September 24, 2021: NOC 26738Supplement to a New Drug Submission (SNDS) · Addition of a manufacturing site of the drug substance, change in the specification for the drug substance and change in the specification for the drug product.
  • June 8, 2012: NOC 13368Abbreviated New Drug Submission (ANDS) · New manufacturer and product name

Other DINs named SIMVASTATIN